“Prior authorization has become increasingly utilized by insurers who provide no rationale or data to justify its implementation. This often results in serious health care access issues and adverse patient outcomes due to significant delays or outright denial of care. Instead of getting timely treatment, many patients have told us that the stress of fighting their own insurance company exacerbates their conditions. It’s unconscionable that patients are often put through an administrative obstacle course when they should be getting quickly approved for medically necessary care,” Barbara Jung, MD, president of the American Gastroenterological Association, said in a Sept. 21 email shared with Becker’s.
During the gathering attendees also vocalized their concerns about UnitedHealthcare’s proposed gold card prior authorization policy.
Ninety-five percent of respondents to a 2023 survey of AGA’s membership say that prior authorization restrictions have affected patient access to clinically appropriate treatments and patient clinical outcomes.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.